Updated:
National Institute on Alcohol Abuse and Alcoholism
George Kunos leads NIAAA, the $500M+ NIH institute funding alcohol research worldwide — 400 staff, COGA study, clinical trials.
National Institute on Alcohol Abuse and Alcoholism
NIAAA was established in 1970 under the U.S. National Institutes of Health (NIH) to lead the federal response to alcohol misuse and alcoholism. Its founding director, Morris Chafetz, set the institute's dual mandate: generate fundamental science and translate findings into clinical practice. The agency's budget, appropriated annually by Congress, has grown from roughly $20M in 1970 to over $500M in recent years (per NIH Office of Budget, FY2024). Strategically, NIAAA allocates roughly 60 percent of its budget to extramural research grants — funding academic investigators at 500+ universities globally — and the remainder to intramural research at its own Division of Intramural Clinical and Biological Research. Its asset-class mix spans basic neuroscience (alcohol effects on brain circuitry), clinical trials for pharmacotherapies (e.g., naltrexone, acamprosate), epidemiological studies (NIAAA's National Epidemiologic Survey on Alcohol and Related Conditions), and implementation science. Named portfolio includes the COMBINE Study (a landmark multi-site trial on behavioral and pharmacological treatments, 2006) and the Collaborative Studies on the Genetics of Alcoholism (COGA), ongoing since 1989 (per NIAAA, public record). Geographic reach is predominantly U.S.-based but includes international collaborations through the World Health Organization. NIAAA employs roughly 400 full-time staff, including 50 principal investigators with doctoral degrees. It operates a single headquarters in Rockville, Maryland, with no regional offices. Adjacent to its research function, NIAAA maintains the National Alcohol Screening Program and runs the public-facing Alcohol Treatment Navigator. In FY2023, NIAAA launched the "Stop Underage Drinking" portal and published updated guidelines for low-risk drinking levels (per NIAAA annual report, FY2023). Structurally, NIAAA's differentiator is its public-sector positioning: it does not manage private capital or pursue returns, but rather functions as the primary national funder and scientific coordinator for the alcohol research ecosystem. Its governance, overseen by the NIH Director and an advisory council of non-federal scientists, gives it unusual independence from commercial conflicts — a rarity among U.S. biomedical research funders. The institute has no single-family-office or wealth-management role whatsoever.
General information
Firm type
other
Year founded
1970
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Rockville
Corporate office
Rockville, MD, United States
Principals
George Kunos
Acting Director
Sector focus
Frequently asked questions
Who runs investment decisions at the National Institute on Alcohol Abuse and Alcoholism?
The NIAAA Director, appointed by the NIH Director, sets the institute's scientific priorities and budget allocation. As of 2025, acting director George Kunos oversees strategic direction, with final budget authority vested in Congress via the NIH appropriations process (per NIH Office of Budget, FY2024).
How does NIAAA source its research portfolio?
NIAAA uses a competitive peer-review process managed by the NIH Center for Scientific Review. Researchers apply for R01, R21, and U01 grants; applications undergo rigorous scientific and ethical review by independent study sections (per NIH Grants Policy Statement). The intramural program recruits scientists via open fellowship and tenure-track hiring.
Is NIAAA structured as a single family office or does it operate more as a federal agency?
NIAAA is a federal research institute within the U.S. National Institutes of Health, part of the Department of Health and Human Services. It has no wealth-management or investment functions whatsoever. It is best understood as a government-funded research agency with a dual intramural-extramural research model (per NIH organizational chart).
What research stages does NIAAA typically fund?
NIAAA funds a full translational pipeline: basic neuroscience (R01 grants on alcohol effects on brain circuits), epidemiological surveys (NESARC), clinical trials for pharmacotherapies (e.g., COMBINE Study), implementation science, and public health interventions (e.g., NIAAA's Alcohol Treatment Navigator). Its portfolio spans discovery through population-level application (per NIAAA strategic plan, 2023–2027).
Which sectors does NIAAA explicitly avoid?
NIAAA does not fund research on other drugs of abuse (those fall under the National Institute on Drug Abuse), cancer-related alcohol studies (National Cancer Institute), or commercial development of alcohol products. It strictly funds alcohol-focused biomedical science and public health research (per NIAAA mission statement).
How is NIAAA related to the broader NIH?
NIAAA is one of 27 institutes and centers within the National Institutes of Health. It was created by the Comprehensive Alcohol Abuse and Alcoholism Prevention, Treatment, and Rehabilitation Act of 1970. Its budget is determined through the NIH's annual appropriation from Congress, with scientific priorities set by the NIAAA Director and an advisory council of non-federal scientists (per NIAAA enabling legislation).
Where does the underlying funding come from?
NIAAA receives its budget entirely from U.S. federal appropriations through the Department of Health and Human Services. For FY2024, the NIH-wide budget was approximately $48B; NIAAA's share was approximately $532M (per NIH Office of Budget). No private capital or endowment supports its operations.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: